Association between HLA-Cw*0602 polymorphism and psoriasis risk: A meta-analysis

Genetics and Molecular Research

Volumn 10, Issue 4, 2011, Pages 3109-3120

  Wu, D ^a   Wu, Y ^b   Liu, J L ^b   Wang, B ^b   Zhang, X D ^a  

^a Department of Dermatology   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Human leukocyte antigen; Meta analysis; Polymorphism; Psoriasis; Risk

Indexed keywords

HLA ANTIGEN; HLA C ANTIGEN;

ALLELE; ARTICLE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HETEROZYGOTE; HLA SYSTEM; HOMOZYGOTE; HUMAN; PSORIASIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; ASIAN; BIBLIOGRAPHIC DATABASE; CASE CONTROL STUDY; CAUCASIAN; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; POLYMERASE CHAIN REACTION; RISK;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DATABASES, BIBLIOGRAPHIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; MALE; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PSORIASIS; RISK;

EID: 84861813719     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2011.December.15.2     Document Type: Article

References (45)

1. Asumalahti K, Laitinen T, Itkonen-Vatjus R, Lokki ML, et al. (2000). A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Hum. Mol. Genet. 9: 1533-1542.
2. Attia J, Thakkinstian A and D'Este C (2003). Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J. Clin. Epidemiol. 56: 297-303.
3. Brandrup F, Holm N, Grunnet N, Henningsen K, et al. (1982). Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Derm. Venereol. 62: 229-236.
4. Brazzelli V, Quaglini M, Martinetti M, Nolli G, et al. (2000). A peculiar sequence motif in the alpha-1-domain of the HLA-C molecule in psoriasis. Dermatology 200: 99-103.
5. Chandran V and Raychaudhuri SP (2010). Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J. Autoimmun. 34: J314-J321.
6. Chang YT, Shiao YM, Chin PJ, Liu YL, et al. (2004). Genetic polymorphisms of the HCR gene and a genomic segment in close proximity to HLA-C are associated with patients with psoriasis in Taiwan. Br. J. Dermatol. 150: 1104-1111.
7. Chang YT, Liu HN, Shiao YM, Lin MW, et al. (2005). A study of PSORS1C1 gene polymorphisms in Chinese patients with psoriasis. Br. J. Dermatol. 153: 90-96.
8. Chang YT, Chou CT, Shiao YM, Lin MW, et al. (2006). Psoriasis vulgaris in Chinese individuals is associated with PSORS1C3 and CDSN genes. Br. J. Dermatol. 155: 663-669.
9. Duffin KC, Chandran V, Gladman DD, Krueger GG, et al. (2008). Genetics of psoriasis and psoriatic arthritis: update and future direction. J. Rheumatol. 35: 1449-1453.
10. Fan X, Yang S, Sun LD, Liang YH, et al. (2007). Comparison of clinical features of HLA-Cw*0602-positive and-negative psoriasis patients in a Han Chinese population. Acta Derm. Venereol. 87: 335-340.
11. Farber EM, Nall ML and Watson W (1974). Natural history of psoriasis in 61 twin pairs. Arch Dermatol. 109: 207-211.
12. Fojtíková M, Stolfa J, Novota P, Cejkova P, et al. (2009). HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population. Rheumatol. Int. 29: 1293-1299.
13. Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, et al. (1999). The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum. 42: 1010-1016.
14. Griffiths CE and Barker JN (2007). Pathogenesis and clinical features of psoriasis. Lancet 370: 263-271.
15. Gudjonsson JE, Karason A, Antonsdottir A, Runarsdottir EH, et al. (2003). Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes. Br. J. Dermatol. 148: 233-235.
16. Gudjonsson JE, Johnston A, Sigmundsdottir H and Valdimarsson H (2004). Immunopathogenic mechanisms in psoriasis. Clin. Exp. Immunol. 135: 1-8.
17. Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558.
18. Holm SJ, Sanchez F, Carlen LM, Mallbris L, et al. (2005a). HLA-Cw*0602 associates more strongly to psoriasis in the Swedish population than variants of the novel 6p21.3 gene PSORS1C3. Acta Derm. Venereol. 85: 2-8.
19. Holm SJ, Sakuraba K, Mallbris L, Wolk K, et al. (2005b). Distinct HLA-C/KIR genotype profile associates with guttate psoriasis. J. Invest. Dermatol. 125: 721-730.
20. Jobim M, Jobim LF, Salim PH, Cestari TF, et al. (2008). A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with Psoriasis vulgaris. Tissue Antigens 72: 392-396.
21. Liu Y, Helms C, Liao W, Zaba LC, et al. (2008). A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4: e1000041.
22. Lowes MA, Bowcock AM and Krueger JG (2007). Pathogenesis and therapy of psoriasis. Nature 445: 866-873.
23. Luft FC (2005). Light shed on the common skin scourge, psoriasis. J. Mol. Med. 83: 933-934.
24. Luszczek W, Kubicka W, Cislo M, Nockowski P, et al. (2003). Strong association of HLA-Cw6 allele with juvenile psoriasis in Polish patients. Immunol. Lett. 85: 59-64.
25. Mallbris L, Wolk K, Sanchez F and Stahle M (2009). HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study. BMC Dermatol. 9: 5.
26. Martínez-Borra J, Gonzalez S, Santos-Juanes J, Sanchez del RJ, et al. (2003). Psoriasis vulgaris and psoriatic arthritis share a 100 kb susceptibility region telomeric to HLA-C. Rheumatology 42: 1089-1092.
27. Martínez-Borra J, Brautbar C, Gonzalez S, Enk CD, et al. (2005). The region of 150 kb telometic to HLA-C is associated with psoriasis in the Jewish population. J. Invest. Dermatol. 125: 928-932.
28. Nair RP, Stuart PE, Nistor I, Hiremagalore R, et al. (2006). Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am. J. Hum. Genet. 78: 827-851.
29. Naldi L and Mercuri SR (2010). Epidemiology of comorbidities in psoriasis. Dermatol. Ther. 23: 114-118.
30. Nestle FO, Kaplan DH and Barker J (2009). Psoriasis. N. Engl. J. Med. 361: 496-509.
31. Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680.
32. Płoski R, Luszczek W, Kuśnierczyk P, Nockowski P, et al. (2006). A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis. Hum. Immunol. 67: 521-526.
33. Rani R, Narayan R, Fernandez-Vina MA and Stastny P (1998). Role of HLA-B and C alleles in development of psoriasis in patients from North India. Tissue Antigens 51: 618-622.
34. Raychaudhuri SP and Gross J (2000a). A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr. Dermatol. 17: 174-178.
35. Raychaudhuri SP and Gross J (2000b). Psoriasis risk factors: role of lifestyle practices. Cutis 66: 348-352.
36. Raychaudhuri SP and Farber EM (2001). The prevalence of psoriasis in the world. J. Eur. Acad. Dermatol. Venereol. 15: 16-17.
37. Reveille JD and Williams FM (2006). Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. Best Pract. Res. Clin. Rheumatol. 20: 1159-1179.
38. Sánchez F, Holm SJ, Mallbris L, O'Brien KP, et al. (2004). STG does not associate with psoriasis in the Swedish population. Exp. Dermatol. 13: 413-418.
39. Schon MP and Boehncke WH (2005). Psoriasis. N. Engl. J. Med. 352: 1899-1912.
40. Szczerkowska-Dobosz A (2005). Human leukocyte antigens as psoriasis inheritance and susceptibility markers. Arch. Immunol. Ther. Exp. 53: 428-433.
41. Valdimarsson H (2007). The genetic basis of psoriasis. Clin. Dermatol. 25: 563-567.
42. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, et al. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18: 805-835.
43. Watson W, Cann HM, Farber EM and Nall ML (1972). The genetics of psoriasis. Arch. Dermatol. 105: 197-207.
44. Zhang XJ, Zhang AP, Yang S, Gao M, et al. (2003). Association of HLA class I alleles with Psoriasis vulgaris in southeastern Chinese Hans. J. Dermatol. Sci. 33: 1-6.
45. Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137.